newsfilter
← Latest News
GlobeNewswire·

Krystal Biotech Announces Fourth Quarter and Full Year 2024 Financial and Operating Results

Fourth quarter revenues increased 116% to $91.1 million versus fourth quarter of 2023 Full year revenues increased 473% to $290.5 million versus 2023 CFF TDN granted full sanctioning of KB407 Phase 1 protocol Strong